1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Relapsed T-Cell Lymphoma: new trials by email Literature Review of Relapsed T-Cell Lymphoma trials Research Report on Relapsed T-Cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Single Arm Study Evaluating the Efficacy and Safety of Pralatrexate in Subjects With Relapsed or Refractory PTCL pralatrexate, Vitamin B12 and folic acid - Refractory Peripheral T-Cell Lymphoma, Relapsed T-Cell Lymphoma | Phase 3 | Completed | Mundipharma (China) Pharmaceutical Co. Ltd | 85 | 2015-09-10 | 2019-10-01 |
Lymphoma, T-Cell (1) · Lymphoma, T-Cell, Peripheral (1)
Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
10-propargyl-10-deazaaminopterin (1) · Folic Acid (1) · Vitamin B 12 (1)
Mundipharma (China) Pharmaceutical Co. Ltd (1)
China (1)
Victoria YU (1)